🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Scott F. Huntington

Yale Cancer Center

ORCID: 0000-0001-7071-6475

Also affiliated with Yale University, Smilow Cancer Hospital

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.467Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Helicobacter pylori–negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysis

American Journal of Clinical Pathology(2023)10.1093/ajcp/aqad088

Top 41%

0.467DataRank

Top 41%11 citations

Alexa J. Siddon, Scott F. Huntington, Dhanpat Jain, Sean X. Gu

Papers

Driven by 13 papers — median percentile 59. Top paper: “COVID-19 in patients with CLL: improved survival outcomes and update on management strategies”.

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Blood(2021)10.1182/blood.2021011841

N/A

3.5DataRank · unranked

70 citations

Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids +47 more

Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers

Journal of Pain and Symptom Management(2020)10.1016/j.jpainsymman.2019.12.373

N/A

0.829DataRank · unranked

23 citations

Anna Revette, Scott F. Huntington, James A. Tulsky, Gregory A. Abel, Oreofe O. Odejide +1 more

DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study

American Journal of Hematology(2023)10.1002/ajh.26888

N/A

0.470DataRank · unranked

22 citations

Stephen J. Schuster, Wei Ding, Amber B. Koehler, Danielle M. Brander, Allison Rosenthal +10 more

Helicobacter pylori–negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysis

American Journal of Clinical Pathology(2023)10.1093/ajcp/aqad088

Top 41%

0.467DataRank

Top 41%11 citations

Alexa J. Siddon, Scott F. Huntington, Dhanpat Jain, Sean X. Gu

Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.70012

N/A

0.330DataRank · unranked

8 citations

Scott F. Huntington, Amer M. Zeidan, Jan Philipp Bewersdorf

The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.16642

N/A

0.330DataRank · unranked

8 citations

Krystal Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Jamy +9 more

Integrating 4 Measures to Evaluate Physical Function in Patients with Cancer (In4M): Protocol for a prospective study

medRxiv(2023)10.1101/2023.03.08.23286924

N/A

0.287DataRank · unranked

4 citations

Paul G. Kluetz, Vishal Bhatnagar, Abbie Brown, Elizabeth Cathcart-Rake, Matthew Diamond +16 more

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Blood Advances(2025)10.1182/bloodadvances.2025016532

N/A

0DataRank · unranked

1 citations

Kishan Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez +8 more

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib

Blood Neoplasia(2025)10.1016/j.bneo.2025.100159

N/A

0DataRank · unranked

0 citations

Jessica M. Stempel, Rory M. Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze +6 more

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States

Blood Advances(2021)10.1182/bloodadvances.2021005642

N/A

0DataRank · unranked

12 citations

Stephanie Prozora, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze +4 more

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Blood(2021)10.1182/blood.2021012888

N/A

0DataRank · unranked

95 citations

Daniel Reed, Ashley McCook, Jeremy Sen, Christian Barlow, Mary‐Kate Malecek +48 more

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia

Blood(2022)10.1182/blood.2021014401

N/A

0DataRank · unranked

11 citations

Kishan Patel, George Goshua, Rory M. Shallis, Nikolai A. Podoltsev, Scott F. Huntington +2 more

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

0DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more